183 related articles for article (PubMed ID: 37244881)
1. Relapse of minimal change disease following the third mRNA COVID-19 vaccination: a case report and literature review.
Teragaki M; Tanaka M; Yamamoto H; Watanabe T; Takeoka J; Fukumi A; Maeda K; Takami Y; Saita H; Iwanari S; Ikeda M; Takeoka H
CEN Case Rep; 2024 Feb; 13(1):53-58. PubMed ID: 37244881
[TBL] [Abstract][Full Text] [Related]
2. Minimal change disease following the Moderna COVID-19 vaccine: first case report.
Thappy S; Thalappil SR; Abbarh S; Al-Mashdali A; Akhtar M; Alkadi MM
BMC Nephrol; 2021 Nov; 22(1):376. PubMed ID: 34763669
[TBL] [Abstract][Full Text] [Related]
3. Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
Lebedev L; Sapojnikov M; Wechsler A; Varadi-Levi R; Zamir D; Tobar A; Levin-Iaina N; Fytlovich S; Yagil Y
Am J Kidney Dis; 2021 Jul; 78(1):142-145. PubMed ID: 33839200
[TBL] [Abstract][Full Text] [Related]
4. Exacerbation of Minimal Change Disease Following mRNA COVID-19 Vaccination.
Pirzadeh A; Emami S; Zuckerman JE; Nobakht N
Am J Case Rep; 2023 Nov; 24():e941621. PubMed ID: 37941318
[TBL] [Abstract][Full Text] [Related]
5. Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report.
Leclerc S; Royal V; Lamarche C; Laurin LP
Am J Kidney Dis; 2021 Oct; 78(4):607-610. PubMed ID: 34242687
[TBL] [Abstract][Full Text] [Related]
6. New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review.
Lim JH; Han MH; Kim YJ; Kim MS; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
J Korean Med Sci; 2021 Aug; 36(30):e218. PubMed ID: 34342187
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine: causal or incidental correlation?
Annicchiarico Petruzzelli L; Minale B; Serio V; De Luca A; Marino Marsilia G; Campione S; Diomedi Camassei F; D'Arcangelo R; Luongo I; Lepore L; Giannattasio P; Molino D; Pirro L; Lonardo MC; Malgieri G; Pecoraro C
G Ital Nefrol; 2022 Dec; 39(6):. PubMed ID: 36655832
[TBL] [Abstract][Full Text] [Related]
8. Minimal change disease soon after Pfizer-BioNTech COVID-19 vaccination.
Kobayashi S; Fugo K; Yamazaki K; Terawaki H
Clin Kidney J; 2021 Dec; 14(12):2606-2607. PubMed ID: 34938534
[TBL] [Abstract][Full Text] [Related]
9. De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor.
Marinaki S; Kolovou K; Liapis G; Skalioti C; Tsiakas S; Boletis I
Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056345
[TBL] [Abstract][Full Text] [Related]
10. Interventions for minimal change disease in adults with nephrotic syndrome.
Azukaitis K; Palmer SC; Strippoli GF; Hodson EM
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD001537. PubMed ID: 35230699
[TBL] [Abstract][Full Text] [Related]
11. A de novo case of minimal change disease following the first dose of the Moderna mRNA-1273 SARS-CoV-2 vaccine without relapse after the second dose.
Mochizuki RI; Takahashi N; Ikenouchi K; Shoda W; Kuyama T; Takahashi D
CEN Case Rep; 2022 Nov; 11(4):477-481. PubMed ID: 35435622
[TBL] [Abstract][Full Text] [Related]
12. New-onset minimal change disease following the Moderna COVID-19 vaccine.
Kobayashi N; Fujisawa H; Kumagai J; Tanabe M
BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37714559
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of minimal change disease after Pfizer vaccine against COVID-19.
Marampudi S; Beshai R; Banker G
J Osteopath Med; 2022 Oct; 122(10):499-501. PubMed ID: 35700437
[TBL] [Abstract][Full Text] [Related]
14. Minimal change disease following COVID-19 vaccination: A systematic review.
Kechagias KS; Laleye JD; Drmota J; Geropoulos G; Kyrtsonis G; Zafeiri M; Triantafyllidis KK; Stathi D
PLoS One; 2024; 19(3):e0297568. PubMed ID: 38442131
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
16. New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review.
Nakazawa E; Uchimura T; Hirai Y; Togashi H; Oyama Y; Inaba A; Shiga K; Ito S
CEN Case Rep; 2022 May; 11(2):242-246. PubMed ID: 34782983
[TBL] [Abstract][Full Text] [Related]
17. De novo Minimal Change Disease in an Adolescent after Pfizer-BioNTech COVID-19 Vaccination: A Case Report.
Pella E; Sarafidis PA; Alexandrou ME; Stangou M; Nikolaidou C; Kosmidis D; Papagianni A
Case Rep Nephrol Dial; 2022; 12(1):44-49. PubMed ID: 35611026
[TBL] [Abstract][Full Text] [Related]
18. Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases.
Hartley JL; Bailey N; Sharma A; Shawki H
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35246429
[TBL] [Abstract][Full Text] [Related]
19. Podocytopathies related to either COVID-19 infection or its vaccination, our experience and literature review.
Pokharel A; Anderson JD; Deebajah M; Blatt NB; Reddy G; Garlapaty V; Li W; Kanaan HD; Zhang PL
Ultrastruct Pathol; 2023 Sep; 47(5):373-381. PubMed ID: 37463165
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records.
Niesen MJM; Pawlowski C; O'Horo JC; Challener DW; Silvert E; Donadio G; Lenehan PJ; Virk A; Swift MD; Speicher LL; Gordon JE; Geyer HL; Halamka JD; Venkatakrishnan AJ; Soundararajan V; Badley AD
JAMA Netw Open; 2022 Apr; 5(4):e227038. PubMed ID: 35420661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
